Bahisht Pharmaceuticals Private Limited
About Bahisht Pharmaceuticals Private Limited
Data last updated:
Bahisht Pharmaceuticals Private Limited is a private limited company based in Srinagar, Jammu And Kashmir, India. It was incorporated on 24 August 2023.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U46497JK2023PTC014986.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mehraj Ud Din Lone and Mohammad Rafi Sheikh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Alahi Market, Bemina, Srinagar, Jammu and Kashmir, India – 190018.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.49 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹20,988 (net margin 1%) and EBITDA of ₹47,427 (EBITDA margin 2.3%).
Company details
Contact details
Bahisht Pharmaceuticals Private Limited's registered office is in Srinagar, Jammu And Kashmir.
- Registered AddressAlahi Market, Bemina, Srinagar, Jammu and Kashmir, India – 190018
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Bahisht Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bahisht Pharmaceuticals Private Limited, buy the company report.
Financials of Bahisht Pharmaceuticals Private Limited
FY 2025 filings availableBahisht Pharmaceuticals Private Limited reported revenue of ₹20.49 Lakh (up 370% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 370% in the latest year. EBITDA rose 372% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹47,427 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹20,988 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.3% | |
| Net Profit Margin | 1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Bahisht Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bahisht Pharmaceuticals Private Limited
Bahisht Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mehraj Ud Din Lone | Director | 24 Aug 2023 | 3 Years 2 Months | Current |
| Mohammad Rafi Sheikh | Director | 18 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Bahisht Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Confiado Pharmaceuticals Private Limited | ₹20.56 Lakh (FY 2025) | 19.0% | Kannankulangara, Kerala, India | |||
| Sankalp Pharmaceuticals Private Limited | ₹20.51 Lakh (FY 2016) | 12.0% | Bhojpur, Bihar, India | |||
| Bahisht Pharmaceuticals Private Limitedthis company | ₹20.49 Lakh (FY 2025) | ₹20,988 | 1% | 370.0% | Srinagar, Jammu And Kashmir, India | |
| Arcon Pharmaceuticals Private Limited | ₹20.48 Lakh (FY 2025) | -22.0% | Patna, Bihar, India | |||
| Keyares Pharmaceuticals Private Limited | ₹20.42 Lakh (FY 2022) | Patna, Bihar, India | ||||
| Descant Pharmaceuticals Private Limited | ₹20.41 Lakh (FY 2024) | -18.0% | Unnao, Uttar Pradesh, India |
To see the full peer comparison of Bahisht Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Bahisht Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bahisht Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Bahisht Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Bahisht Pharmaceuticals Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Mohammad Ramzan Sheikh ceased to be Director on 19 Sep 2025.
Frequently asked questions
Bahisht Pharmaceuticals is an active private limited company based in Srinagar, Jammu And Kashmir, India. It was incorporated on 24 August 2023 (3+ years old) and is registered under CIN U46497JK2023PTC014986.
Bahisht Pharmaceuticals has 2 current directors:
- Mehraj Ud Din Lone - Director
- Mohammad Rafi Sheikh - Director
The latest financial statements of Bahisht Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Bahisht Pharmaceuticals is U46497JK2023PTC014986. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bahisht Pharmaceuticals was incorporated on 24 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Bahisht Pharmaceuticals by revenue are Confiado Pharmaceuticals Private Limited, Sankalp Pharmaceuticals Private Limited, Arcon Pharmaceuticals Private Limited, Keyares Pharmaceuticals Private Limited, Descant Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohammad Ramzan Sheikh ceased to be Director on 19 Sep 2025. Mohammad Rafi Sheikh was appointed as Director on 18 Dec 2023. Mehraj Ud Din Lone was appointed as Director on 24 Aug 2023. Bahisht Pharmaceuticals has 4 board changes on record in total.
The registered office of Bahisht Pharmaceuticals is at Alahi Market, Bemina, Srinagar, Jammu and Kashmir, India – 190018.
Bahisht Pharmaceuticals can be reached at its registered office: Alahi Market, Bemina, Srinagar, Jammu and Kashmir, India – 190018.
Bahisht Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Jammu.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
